Is INNMF or QYLD a better dividend investment in 2026?

INNMF currently yields 1081.08% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: INNMF offers higher current income.

What is the dividend yield difference between INNMF and QYLD?

INNMF has a forward dividend yield of 1081.08% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 1069.16 percentage points.

Home › Compare › INNMF vs QYLD

INNMF vs QYLD: Dividend Comparison 2026

INNMF yields 1081.08% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 INNMF wins by $37306288.16M in total portfolio value

INVESTMENT

TIME HORIZON10 years

INNMF

● Live price

1081.08%

Share price

$0.19

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37306288.18M

Annual income

$31,563,031,594,132.85

Full INNMF calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — INNMF vs QYLD

📍 INNMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	INNMF	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, INNMF + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

INNMF pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INNMF

Annual income on $10K today (after 15% tax)

$91,891.89/yr

After 10yr DRIP, annual income (after tax)

$26,828,576,855,012.92/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, INNMF beats the other by $26,828,576,850,202.51/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INNMF + QYLD for your $10,000?

INNMF: 50%QYLD: 50%

100% QYLD50/50100% INNMF

Portfolio after 10yr

$18653144.11M

Annual income

$15,781,515,799,896.08/yr

Blended yield

84.61%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INNMF buys

QYLD buys

No recent congressional trades found for INNMF or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricINNMFQYLD

Forward yield	1081.08% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$37306288.18M ✓	$25.4K
Annual income after 10y	$31,563,031,594,132.85 ✓	$5,659.31
Total dividends collected	$36872092.59M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: INNMF vs QYLD ($10,000, DRIP)

Year	INNMF Portfolio	INNMF Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$118,808	$108,108.11	$10,352	$1,192.36	+$108.5K → INNMF
2	$1,327,510	$1,200,385.03	$10,830	$1,347.57	+$1.32M → INNMF
3	$13,955,553	$12,535,117.70	$11,460	$1,539.07	+$13.94M → INNMF
4	$138,087,992	$123,155,549.73	$12,275	$1,777.84	+$138.08M → INNMF
5	$1,286,637,044	$1,138,882,892.71	$13,323	$2,078.95	+$1286.62M → INNMF
6	$11,294,046,827	$9,917,345,190.59	$14,667	$2,463.34	+$11294.03M → INNMF
7	$93,443,552,038	$81,358,921,932.82	$16,396	$2,960.57	+$93443.54M → INNMF
8	$729,086,740,275	$629,102,139,594.15	$18,631	$3,612.97	+$729086.72M → INNMF
9	$5,367,529,524,068	$4,587,406,711,974.06	$21,548	$4,482.15	+$5367529.50M → INNMF
10	$37,306,288,184,886	$31,563,031,594,132.85	$25,398	$5,659.31	+$37306288.16M → INNMF

INNMF vs QYLD: Complete Analysis 2026

INNMF — Stock

Amplia Therapeutics Limited, a pharmaceutical company, focuses on development of focal adhesion kinase (FAK) inhibitors for oncology and chronic fibrosis in Australia. The company's product pipeline includes AMP945, an inhibitor of FAK, for pancreatic cancer and idiopathic pulmonary fibrosis, as well as other cancers and fibrotic diseases indications, that has completed Phase I clinical trial; and AMP886 for cancer and fibrotic disease indication. It has a collaboration agreement with the Garvan Institute of Media Research in Sydney. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.

Full INNMF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this INNMF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INNMF vs SCHD INNMF vs JEPI INNMF vs O INNMF vs KO INNMF vs MAIN INNMF vs XYLD INNMF vs JEPQ INNMF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.